Clinical Topics & News
Boosting Blood Cells for Transplant Patients
Fed Pract. 2009 January;26(1):16
Recommended Reading
Clinical Topics
-
Leukemia rates two to three times higher in children born near fracking -
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF Publish date: June 24, 2022 -
Severe COVID two times higher for cancer patients Publish date: November 8, 2021 -
Transfusions, readmissions higher for patients with CLL after cardiac surgery Publish date: September 20, 2021 -
One in three cancer articles on social media has wrong info Publish date: August 4, 2021
Digital Edition
-
AVAHO 2021 Meeting Posters and Abstracts Publish date: September 22, 2021 -
Advances in Hematology and Oncology Publish date: September 3, 2021 -
Advances in Hematology and Oncology Publish date: May 20, 2021 -
August 2020 Advances in Precision Oncology -
Abstracts Presented at the 2020 AVAHO Annual Meeting (Digital Edition)
Multimedia
-
Researchers propose new risk groups for NK-AML Publish date: May 8, 2019 -
Study highlights lack of data on transgender leukemia patients Publish date: April 19, 2019 -
ALF 2019 showcases evolving treatment of AML Publish date: April 19, 2019
Conference Coverage
-
Multiprong strategy makes clinical trials less White Publish date: June 23, 2023 -
CBSM phone app eases anxiety, depression in cancer patients Publish date: June 23, 2023 -
Huge underuse of germline testing for cancer patients Publish date: June 22, 2023 -
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncology Publish date: June 15, 2023 -
Cross-border U.S.-Mexican collaboration drives up ALL survival Publish date: June 4, 2023 -
Patients with blood cancers underutilize palliative care Publish date: June 23, 2022 -
Novel COVID-19 vaccine could fill the void for patients with blood cancers Publish date: April 18, 2022 -
Many patients, doctors unaware of advancements in cancer care Publish date: October 4, 2021 -
Most community-based oncologists skip biomarker testing Publish date: September 21, 2021 -
Ponatinib/blinatumomab start strong against Ph+ALL Publish date: June 25, 2021
Prognostic factors of bladder cancer
Question 1 of 5